世界のエリスロポエチン(EPO)治療薬市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV05784)
◆英語タイトル:Global Erythropoietin (EPO) Drugs Market Insights and Forecast to 2026
◆商品コード:QYR20NV05784
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月
◆ページ数:111
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥413,400見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥620,100見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥826,800見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートはエリスロポエチン(EPO)治療薬の世界市場について調査・分析した資料です。種類別(エポエチンアルファ、ダルベポエチンアルファ、エポエチンベータ、その他)の市場規模、用途別(貧血、腎障害、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別エリスロポエチン(EPO)治療薬の競争状況、市場シェア
・世界のエリスロポエチン(EPO)治療薬市場:種類別市場規模 2015年-2020年(エポエチンアルファ、ダルベポエチンアルファ、エポエチンベータ、その他)
・世界のエリスロポエチン(EPO)治療薬市場:種類別市場規模予測 2021年-2026年(エポエチンアルファ、ダルベポエチンアルファ、エポエチンベータ、その他)
・世界のエリスロポエチン(EPO)治療薬市場:用途別市場規模 2015年-2020年(貧血、腎障害、その他)
・世界のエリスロポエチン(EPO)治療薬市場:用途別市場規模予測 2021年-2026年(貧血、腎障害、その他)
・北米のエリスロポエチン(EPO)治療薬市場分析:米国、カナダ
・ヨーロッパのエリスロポエチン(EPO)治療薬市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのエリスロポエチン(EPO)治療薬市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のエリスロポエチン(EPO)治療薬市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのエリスロポエチン(EPO)治療薬市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Amgen、Johnson & Johnson、Roche、Galenica、Emcure、Kyowa Hakko Kirin、3SBio、Biocon、LG Life Sciences
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

EPO is a naturally occurring hormone produced by cells in the kidneys that regulate the production of red blood cells in bone marrow.
Increasing incidence of chronic diseases such as end-stage renal diseases, cancer, and HIV is expected to accelerate demand for EPO-stimulating agents as these diseases may cause anemia. To curb rising incidence of anemia, demand for erythropoietin drugs is expected to increase over the coming years.

Market Analysis and Insights: Global Erythropoietin (EPO) Drugs Market
The global Erythropoietin (EPO) Drugs market size is projected to reach US$ 9012.4 million by 2026, from US$ 8482.1 million in 2020, at a CAGR of 5.8%% during 2021-2026.

Global Erythropoietin (EPO) Drugs Scope and Market Size
Erythropoietin (EPO) Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Erythropoietin (EPO) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Erythropoietin (EPO) Drugs market is segmented into
Epoetin-alfa
Darbepoetin-alfa
Epoetin-beta
Others

Segment by Application, the Erythropoietin (EPO) Drugs market is segmented into
Anemia
Kidney Disorders
Other

Regional and Country-level Analysis
The Erythropoietin (EPO) Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Erythropoietin (EPO) Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Erythropoietin (EPO) Drugs Market Share Analysis
Erythropoietin (EPO) Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Erythropoietin (EPO) Drugs business, the date to enter into the Erythropoietin (EPO) Drugs market, Erythropoietin (EPO) Drugs product introduction, recent developments, etc.

The major vendors covered:
Amgen
Johnson & Johnson
Roche
Galenica
Emcure
Kyowa Hakko Kirin
3SBio
Biocon
LG Life Sciences

【レポートの目次】

1 Study Coverage
1.1 Erythropoietin (EPO) Drugs Product Introduction
1.2 Market Segments
1.3 Key Erythropoietin (EPO) Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Erythropoietin (EPO) Drugs Market Size Growth Rate by Type
1.4.2 Epoetin-alfa
1.4.3 Darbepoetin-alfa
1.4.4 Epoetin-beta
1.4.5 Others
1.5 Market by Application
1.5.1 Global Erythropoietin (EPO) Drugs Market Size Growth Rate by Application
1.5.2 Anemia
1.5.3 Kidney Disorders
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Erythropoietin (EPO) Drugs Market Size, Estimates and Forecasts
2.1.1 Global Erythropoietin (EPO) Drugs Revenue 2015-2026
2.1.2 Global Erythropoietin (EPO) Drugs Sales 2015-2026
2.2 Global Erythropoietin (EPO) Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Erythropoietin (EPO) Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Erythropoietin (EPO) Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Erythropoietin (EPO) Drugs Competitor Landscape by Players
3.1 Erythropoietin (EPO) Drugs Sales by Manufacturers
3.1.1 Erythropoietin (EPO) Drugs Sales by Manufacturers (2015-2020)
3.1.2 Erythropoietin (EPO) Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Erythropoietin (EPO) Drugs Revenue by Manufacturers
3.2.1 Erythropoietin (EPO) Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Erythropoietin (EPO) Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Erythropoietin (EPO) Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Erythropoietin (EPO) Drugs Revenue in 2019
3.2.5 Global Erythropoietin (EPO) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Erythropoietin (EPO) Drugs Price by Manufacturers
3.4 Erythropoietin (EPO) Drugs Manufacturing Base Distribution, Product Types
3.4.1 Erythropoietin (EPO) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Erythropoietin (EPO) Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Erythropoietin (EPO) Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Erythropoietin (EPO) Drugs Market Size by Type (2015-2020)
4.1.1 Global Erythropoietin (EPO) Drugs Sales by Type (2015-2020)
4.1.2 Global Erythropoietin (EPO) Drugs Revenue by Type (2015-2020)
4.1.3 Erythropoietin (EPO) Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Erythropoietin (EPO) Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Erythropoietin (EPO) Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Erythropoietin (EPO) Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Erythropoietin (EPO) Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Erythropoietin (EPO) Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Erythropoietin (EPO) Drugs Market Size by Application (2015-2020)
5.1.1 Global Erythropoietin (EPO) Drugs Sales by Application (2015-2020)
5.1.2 Global Erythropoietin (EPO) Drugs Revenue by Application (2015-2020)
5.1.3 Erythropoietin (EPO) Drugs Price by Application (2015-2020)
5.2 Erythropoietin (EPO) Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Erythropoietin (EPO) Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Erythropoietin (EPO) Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Erythropoietin (EPO) Drugs Price Forecast by Application (2021-2026)

6 North America
6.1 North America Erythropoietin (EPO) Drugs by Country
6.1.1 North America Erythropoietin (EPO) Drugs Sales by Country
6.1.2 North America Erythropoietin (EPO) Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Erythropoietin (EPO) Drugs Market Facts & Figures by Type
6.3 North America Erythropoietin (EPO) Drugs Market Facts & Figures by Application

7 Europe
7.1 Europe Erythropoietin (EPO) Drugs by Country
7.1.1 Europe Erythropoietin (EPO) Drugs Sales by Country
7.1.2 Europe Erythropoietin (EPO) Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Erythropoietin (EPO) Drugs Market Facts & Figures by Type
7.3 Europe Erythropoietin (EPO) Drugs Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Erythropoietin (EPO) Drugs by Region
8.1.1 Asia Pacific Erythropoietin (EPO) Drugs Sales by Region
8.1.2 Asia Pacific Erythropoietin (EPO) Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Erythropoietin (EPO) Drugs Market Facts & Figures by Type
8.3 Asia Pacific Erythropoietin (EPO) Drugs Market Facts & Figures by Application

9 Latin America
9.1 Latin America Erythropoietin (EPO) Drugs by Country
9.1.1 Latin America Erythropoietin (EPO) Drugs Sales by Country
9.1.2 Latin America Erythropoietin (EPO) Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Erythropoietin (EPO) Drugs Market Facts & Figures by Type
9.3 Central & South America Erythropoietin (EPO) Drugs Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Erythropoietin (EPO) Drugs by Country
10.1.1 Middle East and Africa Erythropoietin (EPO) Drugs Sales by Country
10.1.2 Middle East and Africa Erythropoietin (EPO) Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Erythropoietin (EPO) Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Erythropoietin (EPO) Drugs Market Facts & Figures by Application

11 Company Profiles
11.1 Amgen
11.1.1 Amgen Corporation Information
11.1.2 Amgen Description and Business Overview
11.1.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amgen Erythropoietin (EPO) Drugs Products Offered
11.1.5 Amgen Related Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Corporation Information
11.2.2 Johnson & Johnson Description and Business Overview
11.2.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Johnson & Johnson Erythropoietin (EPO) Drugs Products Offered
11.2.5 Johnson & Johnson Related Developments
11.3 Roche
11.3.1 Roche Corporation Information
11.3.2 Roche Description and Business Overview
11.3.3 Roche Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Roche Erythropoietin (EPO) Drugs Products Offered
11.3.5 Roche Related Developments
11.4 Galenica
11.4.1 Galenica Corporation Information
11.4.2 Galenica Description and Business Overview
11.4.3 Galenica Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Galenica Erythropoietin (EPO) Drugs Products Offered
11.4.5 Galenica Related Developments
11.5 Emcure
11.5.1 Emcure Corporation Information
11.5.2 Emcure Description and Business Overview
11.5.3 Emcure Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Emcure Erythropoietin (EPO) Drugs Products Offered
11.5.5 Emcure Related Developments
11.6 Kyowa Hakko Kirin
11.6.1 Kyowa Hakko Kirin Corporation Information
11.6.2 Kyowa Hakko Kirin Description and Business Overview
11.6.3 Kyowa Hakko Kirin Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Kyowa Hakko Kirin Erythropoietin (EPO) Drugs Products Offered
11.6.5 Kyowa Hakko Kirin Related Developments
11.7 3SBio
11.7.1 3SBio Corporation Information
11.7.2 3SBio Description and Business Overview
11.7.3 3SBio Sales, Revenue and Gross Margin (2015-2020)
11.7.4 3SBio Erythropoietin (EPO) Drugs Products Offered
11.7.5 3SBio Related Developments
11.8 Biocon
11.8.1 Biocon Corporation Information
11.8.2 Biocon Description and Business Overview
11.8.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Biocon Erythropoietin (EPO) Drugs Products Offered
11.8.5 Biocon Related Developments
11.9 LG Life Sciences
11.9.1 LG Life Sciences Corporation Information
11.9.2 LG Life Sciences Description and Business Overview
11.9.3 LG Life Sciences Sales, Revenue and Gross Margin (2015-2020)
11.9.4 LG Life Sciences Erythropoietin (EPO) Drugs Products Offered
11.9.5 LG Life Sciences Related Developments
11.1 Amgen
11.1.1 Amgen Corporation Information
11.1.2 Amgen Description and Business Overview
11.1.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Amgen Erythropoietin (EPO) Drugs Products Offered
11.1.5 Amgen Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Erythropoietin (EPO) Drugs Market Estimates and Projections by Region
12.1.1 Global Erythropoietin (EPO) Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Erythropoietin (EPO) Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Erythropoietin (EPO) Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Erythropoietin (EPO) Drugs Sales Forecast (2021-2026)
12.2.2 North America: Erythropoietin (EPO) Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Erythropoietin (EPO) Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Erythropoietin (EPO) Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Erythropoietin (EPO) Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Erythropoietin (EPO) Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Erythropoietin (EPO) Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Erythropoietin (EPO) Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Erythropoietin (EPO) Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Erythropoietin (EPO) Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Erythropoietin (EPO) Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Erythropoietin (EPO) Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Erythropoietin (EPO) Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Erythropoietin (EPO) Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Erythropoietin (EPO) Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Erythropoietin (EPO) Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Erythropoietin (EPO) Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Erythropoietin (EPO) Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Erythropoietin (EPO) Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Erythropoietin (EPO) Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Erythropoietin (EPO) Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Erythropoietin (EPO) Drugs Market Segments
Table 2. Ranking of Global Top Erythropoietin (EPO) Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Erythropoietin (EPO) Drugs Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Epoetin-alfa
Table 5. Major Manufacturers of Darbepoetin-alfa
Table 6. Major Manufacturers of Epoetin-beta
Table 7. Major Manufacturers of Others
Table 8. Global Erythropoietin (EPO) Drugs Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 9. Global Erythropoietin (EPO) Drugs Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 10. Global Erythropoietin (EPO) Drugs Sales by Regions 2015-2020 (K Pcs)
Table 11. Global Erythropoietin (EPO) Drugs Sales Market Share by Regions (2015-2020)
Table 12. Global Erythropoietin (EPO) Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Erythropoietin (EPO) Drugs Sales by Manufacturers (2015-2020) (K Pcs)
Table 14. Global Erythropoietin (EPO) Drugs Sales Share by Manufacturers (2015-2020)
Table 15. Global Erythropoietin (EPO) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Erythropoietin (EPO) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Erythropoietin (EPO) Drugs as of 2019)
Table 17. Erythropoietin (EPO) Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Erythropoietin (EPO) Drugs Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Erythropoietin (EPO) Drugs Price (2015-2020) (USD/Pcs)
Table 20. Erythropoietin (EPO) Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Erythropoietin (EPO) Drugs Product Type
Table 22. Date of International Manufacturers Enter into Erythropoietin (EPO) Drugs Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Erythropoietin (EPO) Drugs Sales by Type (2015-2020) (K Pcs)
Table 25. Global Erythropoietin (EPO) Drugs Sales Share by Type (2015-2020)
Table 26. Global Erythropoietin (EPO) Drugs Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Erythropoietin (EPO) Drugs Revenue Share by Type (2015-2020)
Table 28. Erythropoietin (EPO) Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 29. Global Erythropoietin (EPO) Drugs Sales by Application (2015-2020) (K Pcs)
Table 30. Global Erythropoietin (EPO) Drugs Sales Share by Application (2015-2020)
Table 31. North America Erythropoietin (EPO) Drugs Sales by Country (2015-2020) (K Pcs)
Table 32. North America Erythropoietin (EPO) Drugs Sales Market Share by Country (2015-2020)
Table 33. North America Erythropoietin (EPO) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Erythropoietin (EPO) Drugs Revenue Market Share by Country (2015-2020)
Table 35. North America Erythropoietin (EPO) Drugs Sales by Type (2015-2020) (K Pcs)
Table 36. North America Erythropoietin (EPO) Drugs Sales Market Share by Type (2015-2020)
Table 37. North America Erythropoietin (EPO) Drugs Sales by Application (2015-2020) (K Pcs)
Table 38. North America Erythropoietin (EPO) Drugs Sales Market Share by Application (2015-2020)
Table 39. Europe Erythropoietin (EPO) Drugs Sales by Country (2015-2020) (K Pcs)
Table 40. Europe Erythropoietin (EPO) Drugs Sales Market Share by Country (2015-2020)
Table 41. Europe Erythropoietin (EPO) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Erythropoietin (EPO) Drugs Revenue Market Share by Country (2015-2020)
Table 43. Europe Erythropoietin (EPO) Drugs Sales by Type (2015-2020) (K Pcs)
Table 44. Europe Erythropoietin (EPO) Drugs Sales Market Share by Type (2015-2020)
Table 45. Europe Erythropoietin (EPO) Drugs Sales by Application (2015-2020) (K Pcs)
Table 46. Europe Erythropoietin (EPO) Drugs Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Erythropoietin (EPO) Drugs Sales by Region (2015-2020) (K Pcs)
Table 48. Asia Pacific Erythropoietin (EPO) Drugs Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Erythropoietin (EPO) Drugs Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Erythropoietin (EPO) Drugs Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Erythropoietin (EPO) Drugs Sales by Type (2015-2020) (K Pcs)
Table 52. Asia Pacific Erythropoietin (EPO) Drugs Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Erythropoietin (EPO) Drugs Sales by Application (2015-2020) (K Pcs)
Table 54. Asia Pacific Erythropoietin (EPO) Drugs Sales Market Share by Application (2015-2020)
Table 55. Latin America Erythropoietin (EPO) Drugs Sales by Country (2015-2020) (K Pcs)
Table 56. Latin America Erythropoietin (EPO) Drugs Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Erythropoietin (EPO) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Erythropoietin (EPO) Drugs Revenue Market Share by Country (2015-2020)
Table 59. Latin America Erythropoietin (EPO) Drugs Sales by Type (2015-2020) (K Pcs)
Table 60. Latin America Erythropoietin (EPO) Drugs Sales Market Share by Type (2015-2020)
Table 61. Latin America Erythropoietin (EPO) Drugs Sales by Application (2015-2020) (K Pcs)
Table 62. Latin America Erythropoietin (EPO) Drugs Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Erythropoietin (EPO) Drugs Sales by Country (2015-2020) (K Pcs)
Table 64. Middle East and Africa Erythropoietin (EPO) Drugs Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Erythropoietin (EPO) Drugs Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Erythropoietin (EPO) Drugs Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Erythropoietin (EPO) Drugs Sales by Type (2015-2020) (K Pcs)
Table 68. Middle East and Africa Erythropoietin (EPO) Drugs Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Erythropoietin (EPO) Drugs Sales by Application (2015-2020) (K Pcs)
Table 70. Middle East and Africa Erythropoietin (EPO) Drugs Sales Market Share by Application (2015-2020)
Table 71. Amgen Corporation Information
Table 72. Amgen Description and Major Businesses
Table 73. Amgen Erythropoietin (EPO) Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 74. Amgen Product
Table 75. Amgen Recent Development
Table 76. Johnson & Johnson Corporation Information
Table 77. Johnson & Johnson Description and Major Businesses
Table 78. Johnson & Johnson Erythropoietin (EPO) Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 79. Johnson & Johnson Product
Table 80. Johnson & Johnson Recent Development
Table 81. Roche Corporation Information
Table 82. Roche Description and Major Businesses
Table 83. Roche Erythropoietin (EPO) Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 84. Roche Product
Table 85. Roche Recent Development
Table 86. Galenica Corporation Information
Table 87. Galenica Description and Major Businesses
Table 88. Galenica Erythropoietin (EPO) Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 89. Galenica Product
Table 90. Galenica Recent Development
Table 91. Emcure Corporation Information
Table 92. Emcure Description and Major Businesses
Table 93. Emcure Erythropoietin (EPO) Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 94. Emcure Product
Table 95. Emcure Recent Development
Table 96. Kyowa Hakko Kirin Corporation Information
Table 97. Kyowa Hakko Kirin Description and Major Businesses
Table 98. Kyowa Hakko Kirin Erythropoietin (EPO) Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 99. Kyowa Hakko Kirin Product
Table 100. Kyowa Hakko Kirin Recent Development
Table 101. 3SBio Corporation Information
Table 102. 3SBio Description and Major Businesses
Table 103. 3SBio Erythropoietin (EPO) Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 104. 3SBio Product
Table 105. 3SBio Recent Development
Table 106. Biocon Corporation Information
Table 107. Biocon Description and Major Businesses
Table 108. Biocon Erythropoietin (EPO) Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 109. Biocon Product
Table 110. Biocon Recent Development
Table 111. LG Life Sciences Corporation Information
Table 112. LG Life Sciences Description and Major Businesses
Table 113. LG Life Sciences Erythropoietin (EPO) Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 114. LG Life Sciences Product
Table 115. LG Life Sciences Recent Development
Table 116. Global Erythropoietin (EPO) Drugs Sales Forecast by Regions (2021-2026) (K Pcs)
Table 117. Global Erythropoietin (EPO) Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 118. Global Erythropoietin (EPO) Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 119. Global Erythropoietin (EPO) Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 120. North America: Erythropoietin (EPO) Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 121. North America: Erythropoietin (EPO) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 122. Europe: Erythropoietin (EPO) Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 123. Europe: Erythropoietin (EPO) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 124. Asia Pacific: Erythropoietin (EPO) Drugs Sales Forecast by Region (2021-2026) (K Pcs)
Table 125. Asia Pacific: Erythropoietin (EPO) Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 126. Latin America: Erythropoietin (EPO) Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 127. Latin America: Erythropoietin (EPO) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Middle East and Africa: Erythropoietin (EPO) Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 129. Middle East and Africa: Erythropoietin (EPO) Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 131. Key Challenges
Table 132. Market Risks
Table 133. Main Points Interviewed from Key Erythropoietin (EPO) Drugs Players
Table 134. Erythropoietin (EPO) Drugs Customers List
Table 135. Erythropoietin (EPO) Drugs Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Erythropoietin (EPO) Drugs Product Picture
Figure 2. Global Erythropoietin (EPO) Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Epoetin-alfa Product Picture
Figure 4. Darbepoetin-alfa Product Picture
Figure 5. Epoetin-beta Product Picture
Figure 6. Others Product Picture
Figure 7. Global Erythropoietin (EPO) Drugs Sales Market Share by Application in 2020 & 2026
Figure 8. Anemia
Figure 9. Kidney Disorders
Figure 10. Other
Figure 11. Erythropoietin (EPO) Drugs Report Years Considered
Figure 12. Global Erythropoietin (EPO) Drugs Market Size 2015-2026 (US$ Million)
Figure 13. Global Erythropoietin (EPO) Drugs Sales 2015-2026 (K Pcs)
Figure 14. Global Erythropoietin (EPO) Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Erythropoietin (EPO) Drugs Sales Market Share by Region (2015-2020)
Figure 16. Global Erythropoietin (EPO) Drugs Sales Market Share by Region in 2019
Figure 17. Global Erythropoietin (EPO) Drugs Revenue Market Share by Region (2015-2020)
Figure 18. Global Erythropoietin (EPO) Drugs Revenue Market Share by Region in 2019
Figure 19. Global Erythropoietin (EPO) Drugs Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Erythropoietin (EPO) Drugs Revenue in 2019
Figure 21. Erythropoietin (EPO) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Erythropoietin (EPO) Drugs Sales Market Share by Type (2015-2020)
Figure 23. Global Erythropoietin (EPO) Drugs Sales Market Share by Type in 2019
Figure 24. Global Erythropoietin (EPO) Drugs Revenue Market Share by Type (2015-2020)
Figure 25. Global Erythropoietin (EPO) Drugs Revenue Market Share by Type in 2019
Figure 26. Global Erythropoietin (EPO) Drugs Market Share by Price Range (2015-2020)
Figure 27. Global Erythropoietin (EPO) Drugs Sales Market Share by Application (2015-2020)
Figure 28. Global Erythropoietin (EPO) Drugs Sales Market Share by Application in 2019
Figure 29. Global Erythropoietin (EPO) Drugs Revenue Market Share by Application (2015-2020)
Figure 30. Global Erythropoietin (EPO) Drugs Revenue Market Share by Application in 2019
Figure 31. North America Erythropoietin (EPO) Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 32. North America Erythropoietin (EPO) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Erythropoietin (EPO) Drugs Sales Market Share by Country in 2019
Figure 34. North America Erythropoietin (EPO) Drugs Revenue Market Share by Country in 2019
Figure 35. U.S. Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. U.S. Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. Canada Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Erythropoietin (EPO) Drugs Market Share by Type in 2019
Figure 40. North America Erythropoietin (EPO) Drugs Market Share by Application in 2019
Figure 41. Europe Erythropoietin (EPO) Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 42. Europe Erythropoietin (EPO) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Erythropoietin (EPO) Drugs Sales Market Share by Country in 2019
Figure 44. Europe Erythropoietin (EPO) Drugs Revenue Market Share by Country in 2019
Figure 45. Germany Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. Germany Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. France Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. U.K. Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Italy Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Russia Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Erythropoietin (EPO) Drugs Market Share by Type in 2019
Figure 56. Europe Erythropoietin (EPO) Drugs Market Share by Application in 2019
Figure 57. Asia Pacific Erythropoietin (EPO) Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 58. Asia Pacific Erythropoietin (EPO) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Erythropoietin (EPO) Drugs Sales Market Share by Region in 2019
Figure 60. Asia Pacific Erythropoietin (EPO) Drugs Revenue Market Share by Region in 2019
Figure 61. China Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. China Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. Japan Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. South Korea Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. India Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Australia Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Taiwan Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Indonesia Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Thailand Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Malaysia Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Philippines Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Vietnam Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Erythropoietin (EPO) Drugs Market Share by Type in 2019
Figure 84. Asia Pacific Erythropoietin (EPO) Drugs Market Share by Application in 2019
Figure 85. Latin America Erythropoietin (EPO) Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 86. Latin America Erythropoietin (EPO) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Erythropoietin (EPO) Drugs Sales Market Share by Country in 2019
Figure 88. Latin America Erythropoietin (EPO) Drugs Revenue Market Share by Country in 2019
Figure 89. Mexico Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 90. Mexico Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Brazil Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Argentina Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Erythropoietin (EPO) Drugs Market Share by Type in 2019
Figure 96. Latin America Erythropoietin (EPO) Drugs Market Share by Application in 2019
Figure 97. Middle East and Africa Erythropoietin (EPO) Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 98. Middle East and Africa Erythropoietin (EPO) Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Erythropoietin (EPO) Drugs Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Erythropoietin (EPO) Drugs Revenue Market Share by Country in 2019
Figure 101. Turkey Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 102. Turkey Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Saudi Arabia Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Erythropoietin (EPO) Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. U.A.E Erythropoietin (EPO) Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Erythropoietin (EPO) Drugs Market Share by Type in 2019
Figure 108. Middle East and Africa Erythropoietin (EPO) Drugs Market Share by Application in 2019
Figure 109. North America Erythropoietin (EPO) Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 110. North America Erythropoietin (EPO) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Erythropoietin (EPO) Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. Europe Erythropoietin (EPO) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Erythropoietin (EPO) Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Asia Pacific Erythropoietin (EPO) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Erythropoietin (EPO) Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Latin America Erythropoietin (EPO) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Erythropoietin (EPO) Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Middle East and Africa Erythropoietin (EPO) Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed


【掲載企業】

Amgen、Johnson & Johnson、Roche、Galenica、Emcure、Kyowa Hakko Kirin、3SBio、Biocon、LG Life Sciences

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のエリスロポエチン(EPO)治療薬市場2026:インサイト・予測(Global Erythropoietin (EPO) Drugs Market Insights and Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。